
Morgan Stanley initiates on India’s top four Pharma stocks but only one is an ‘overweight’
Though long-term prospects appear sound, near-term earnings visibility remains limited for Dr. Reddy’s Labs, Cipla, and Lupin, whereas Sun Pharma stands out due to its…








